Global RNA-Based Therapeutics Market Research Report 2021-2025
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Thanks to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry, according to research, the global RNA-Based Therapeutics market is projected to reach USD 992 million by 2020.
Base on type, the oncology segment is emerging as the leading target indication which accounts for 32% of market share, and RNA interference (RNAi) and RNA antisense technologies appear to be dominating the market. RNAi is a gene silencing technology in which RNA molecules inhibit gene expression by targeting and destroying specific mRNA molecules.
Geographically, the North America is dominating the market across the world, which is expected to grow at highest CAGR of 20.9% for the forecast period, due to the government of United States, through its National Institute of Health (NIH), provides funds for RNA therapeutics research, thus assist in propelling the growth of this market. To boost the research activities the U.S. FDA is providing fast track designation to the RNA products, which are in the pipeline.
Region followed by Europe, Europe is experiencing a significant growth for next five years, due to their well established medical insurance, the RNA-Based Therapeutics have a wide adoption by patience; the Asia Pacific is considered as most promising market as their largest population and positive economy, according the report, the Asia Pacific is expected be the largest market globally by 2030.
The global leading companies in this market are Alnylam Pharmaceuticals, Inc., Benitec Biopharma Limited, Cenix BioScience GmbH, Dicerna Pharmaceuticals Inc., Genzyme Corporation, ISIS pharmaceuticals Inc., Quark Pharmaceuticals, Inc., Silence Therapeutics PLC, and Tekmira Pharmaceuticals Corp.
Base on type, the oncology segment is emerging as the leading target indication which accounts for 32% of market share, and RNA interference (RNAi) and RNA antisense technologies appear to be dominating the market. RNAi is a gene silencing technology in which RNA molecules inhibit gene expression by targeting and destroying specific mRNA molecules.
Geographically, the North America is dominating the market across the world, which is expected to grow at highest CAGR of 20.9% for the forecast period, due to the government of United States, through its National Institute of Health (NIH), provides funds for RNA therapeutics research, thus assist in propelling the growth of this market. To boost the research activities the U.S. FDA is providing fast track designation to the RNA products, which are in the pipeline.
Region followed by Europe, Europe is experiencing a significant growth for next five years, due to their well established medical insurance, the RNA-Based Therapeutics have a wide adoption by patience; the Asia Pacific is considered as most promising market as their largest population and positive economy, according the report, the Asia Pacific is expected be the largest market globally by 2030.
The global leading companies in this market are Alnylam Pharmaceuticals, Inc., Benitec Biopharma Limited, Cenix BioScience GmbH, Dicerna Pharmaceuticals Inc., Genzyme Corporation, ISIS pharmaceuticals Inc., Quark Pharmaceuticals, Inc., Silence Therapeutics PLC, and Tekmira Pharmaceuticals Corp.
TABLE OF CONTENTS
Part I RNA-Based Therapeutics Industry Overview
Chapter One RNA-Based Therapeutics Industry Overview
1.1 RNA-Based Therapeutics Definition
1.2 RNA-Based Therapeutics Classification Analysis
1.2.1 RNA-Based Therapeutics Main Classification Analysis
1.2.2 RNA-Based Therapeutics Main Classification Share Analysis
1.3 RNA-Based Therapeutics Application Analysis
1.3.1 RNA-Based Therapeutics Main Application Analysis
1.3.2 RNA-Based Therapeutics Main Application Share Analysis
1.4 RNA-Based Therapeutics Industry Chain Structure Analysis
1.5 RNA-Based Therapeutics Industry Development Overview
1.5.1 RNA-Based Therapeutics Product History Development Overview
1.5.1 RNA-Based Therapeutics Product Market Development Overview
1.6 RNA-Based Therapeutics Global Market Comparison Analysis
1.6.1 RNA-Based Therapeutics Global Import Market Analysis
1.6.2 RNA-Based Therapeutics Global Export Market Analysis
1.6.3 RNA-Based Therapeutics Global Main Region Market Analysis
1.6.4 RNA-Based Therapeutics Global Market Comparison Analysis
1.6.5 RNA-Based Therapeutics Global Market Development Trend Analysis
Chapter Two RNA-Based Therapeutics Up and Down Stream Industry Analysis
2.1 Upstream Raw Materials Analysis
2.1.1 Proportion of Manufacturing Cost
2.1.2 Manufacturing Cost Structure of RNA-Based Therapeutics Analysis
2.2 Down Stream Market Analysis
2.2.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis
Part II Asia RNA-Based Therapeutics Industry (The Report Company Including the Below Listed But Not All)
Chapter Three Asia RNA-Based Therapeutics Market Analysis
3.1 Asia RNA-Based Therapeutics Product Development History
3.2 Asia RNA-Based Therapeutics Competitive Landscape Analysis
3.3 Asia RNA-Based Therapeutics Market Development Trend
Chapter Four 2016-2021 Asia RNA-Based Therapeutics Productions Supply Sales Demand Market Status and Forecast
4.1 2016-2021 RNA-Based Therapeutics Production Overview
4.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
4.3 2016-2021 RNA-Based Therapeutics Demand Overview
4.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
4.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
4.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Chapter Five Asia RNA-Based Therapeutics Key Manufacturers Analysis
5.1 Company A
5.1.1 Company Profile
5.1.2 Product Picture and Specification
5.1.3 Product Application Analysis
5.1.4 Capacity Production Price Cost Production Value
5.1.5 Contact Information
5.2 Company B
5.2.1 Company Profile
5.2.2 Product Picture and Specification
5.2.3 Product Application Analysis
5.2.4 Capacity Production Price Cost Production Value
5.2.5 Contact Information
5.3 Company C
5.3.1 Company Profile
5.3.2 Product Picture and Specification
5.3.3 Product Application Analysis
5.3.4 Capacity Production Price Cost Production Value
5.3.5 Contact Information
5.4 Company D
5.4.1 Company Profile
5.4.2 Product Picture and Specification
5.4.3 Product Application Analysis
5.4.4 Capacity Production Price Cost Production Value
5.4.5 Contact Information
Chapter Six Asia RNA-Based Therapeutics Industry Development Trend
6.1 2021-2025 RNA-Based Therapeutics Production Overview
6.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
6.3 2021-2025 RNA-Based Therapeutics Demand Overview
6.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
6.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
6.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Part III North American RNA-Based Therapeutics Industry (The Report Company Including the Below Listed But Not All)
Chapter Seven North American RNA-Based Therapeutics Market Analysis
7.1 North American RNA-Based Therapeutics Product Development History
7.2 North American RNA-Based Therapeutics Competitive Landscape Analysis
7.3 North American RNA-Based Therapeutics Market Development Trend
Chapter Eight 2016-2021 North American RNA-Based Therapeutics Productions Supply Sales Demand Market Status and Forecast
8.1 2016-2021 RNA-Based Therapeutics Production Overview
8.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
8.3 2016-2021 RNA-Based Therapeutics Demand Overview
8.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
8.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
8.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Chapter Nine North American RNA-Based Therapeutics Key Manufacturers Analysis
9.1 Company A
9.1.1 Company Profile
9.1.2 Product Picture and Specification
9.1.3 Product Application Analysis
9.1.4 Capacity Production Price Cost Production Value
9.1.5 Contact Information
9.2 Company B
9.2.1 Company Profile
9.2.2 Product Picture and Specification
9.2.3 Product Application Analysis
9.2.4 Capacity Production Price Cost Production Value
9.2.5 Contact Information
Chapter Ten North American RNA-Based Therapeutics Industry Development Trend
10.1 2021-2025 RNA-Based Therapeutics Production Overview
10.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
10.3 2021-2025 RNA-Based Therapeutics Demand Overview
10.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
10.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
10.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Part IV Europe RNA-Based Therapeutics Industry Analysis (The Report Company Including the Below Listed But Not All)
Chapter Eleven Europe RNA-Based Therapeutics Market Analysis
11.1 Europe RNA-Based Therapeutics Product Development History
11.2 Europe RNA-Based Therapeutics Competitive Landscape Analysis
11.3 Europe RNA-Based Therapeutics Market Development Trend
Chapter Twelve 2016-2021 Europe RNA-Based Therapeutics Productions Supply Sales Demand Market Status and Forecast
12.1 2016-2021 RNA-Based Therapeutics Production Overview
12.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
12.3 2016-2021 RNA-Based Therapeutics Demand Overview
12.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
12.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
12.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Chapter Thirteen Europe RNA-Based Therapeutics Key Manufacturers Analysis
13.1 Company A
13.1.1 Company Profile
13.1.2 Product Picture and Specification
13.1.3 Product Application Analysis
13.1.4 Capacity Production Price Cost Production Value
13.1.5 Contact Information
13.2 Company B
13.2.1 Company Profile
13.2.2 Product Picture and Specification
13.2.3 Product Application Analysis
13.2.4 Capacity Production Price Cost Production Value
13.2.5 Contact Information
Chapter Fourteen Europe RNA-Based Therapeutics Industry Development Trend
14.1 2021-2025 RNA-Based Therapeutics Production Overview
14.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
14.3 2021-2025 RNA-Based Therapeutics Demand Overview
14.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
14.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
14.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Part V RNA-Based Therapeutics Marketing Channels and Investment Feasibility
Chapter Fifteen RNA-Based Therapeutics Marketing Channels Development Proposals Analysis
15.1 RNA-Based Therapeutics Marketing Channels Status
15.2 RNA-Based Therapeutics Marketing Channels Characteristic
15.3 RNA-Based Therapeutics Marketing Channels Development Trend
15.2 New Firms Enter Market Strategy
15.3 New Project Investment Proposals
Chapter Sixteen Development Environmental Analysis
16.1 China Macroeconomic Environment Analysis
16.2 European Economic Environmental Analysis
16.3 United States Economic Environmental Analysis
16.4 Japan Economic Environmental Analysis
16.5 Global Economic Environmental Analysis
Chapter Seventeen RNA-Based Therapeutics New Project Investment Feasibility Analysis
17.1 RNA-Based Therapeutics Market Analysis
17.2 RNA-Based Therapeutics Project SWOT Analysis
17.3 RNA-Based Therapeutics New Project Investment Feasibility Analysis
Part VI Global RNA-Based Therapeutics Industry Conclusions
Chapter Eighteen 2016-2021 Global RNA-Based Therapeutics Productions Supply Sales Demand Market Status and Forecast
18.1 2016-2021 RNA-Based Therapeutics Production Overview
18.2 2016-2021 RNA-Based Therapeutics Production Market Share Analysis
18.3 2016-2021 RNA-Based Therapeutics Demand Overview
18.4 2016-2021 RNA-Based Therapeutics Supply Demand and Shortage
18.5 2016-2021 RNA-Based Therapeutics Import Export Consumption
18.6 2016-2021 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Chapter Nineteen Global RNA-Based Therapeutics Industry Development Trend
19.1 2021-2025 RNA-Based Therapeutics Production Overview
19.2 2021-2025 RNA-Based Therapeutics Production Market Share Analysis
19.3 2021-2025 RNA-Based Therapeutics Demand Overview
19.4 2021-2025 RNA-Based Therapeutics Supply Demand and Shortage
19.5 2021-2025 RNA-Based Therapeutics Import Export Consumption
19.6 2021-2025 RNA-Based Therapeutics Cost Price Production Value Gross Margin
Chapter Twenty Global RNA-Based Therapeutics Industry Research Conclusions
RELATED REPORTS
Global Bladder Scanners Market 2023
A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder
View ReportGlobal Intraoral Scanner Market 2023
Intraoral scanners provide highly accurate 3D digital impressions of a patients teeth and oral structures. This precision is essential for various dental applications, including the design and fabrication of dental
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
